Logo image of PRX.AS

PROSUS NV (PRX.AS) Stock Fundamental Analysis

AMS:PRX - Euronext Amsterdam - NL0013654783 - Common Stock - Currency: EUR

40.745  +0.77 (+1.91%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to PRX. PRX was compared to 12 industry peers in the Broadline Retail industry. While PRX seems to be doing ok healthwise, there are quite some concerns on its profitability. PRX is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

In the past year PRX was profitable.
Each year in the past 5 years PRX has been profitable.
In multiple years PRX reported negative operating cash flow during the last 5 years.
PRX.AS Yearly Net Income VS EBIT VS OCF VS FCFPRX.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B 15B

1.2 Ratios

Looking at the Return On Assets, with a value of 11.30%, PRX belongs to the top of the industry, outperforming 83.33% of the companies in the same industry.
With a Return On Equity value of 16.31%, PRX perfoms like the industry average, outperforming 41.67% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 0.05%, PRX is doing worse than 83.33% of the companies in the same industry.
Industry RankSector Rank
ROA 11.3%
ROE 16.31%
ROIC 0.05%
ROA(3y)17.49%
ROA(5y)15.28%
ROE(3y)25.28%
ROE(5y)21.22%
ROIC(3y)N/A
ROIC(5y)N/A
PRX.AS Yearly ROA, ROE, ROICPRX.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40

1.3 Margins

PRX has a better Profit Margin (132.98%) than 91.67% of its industry peers.
PRX's Profit Margin has declined in the last couple of years.
The Operating Margin of PRX (0.66%) is worse than 91.67% of its industry peers.
With a Gross Margin value of 42.08%, PRX is not doing good in the industry: 75.00% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of PRX has remained more or less at the same level.
Industry RankSector Rank
OM 0.66%
PM (TTM) 132.98%
GM 42.08%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-6.03%
PM growth 5Y-2.17%
GM growth 3Y7.78%
GM growth 5Y0.45%
PRX.AS Yearly Profit, Operating, Gross MarginsPRX.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 0 100 200 300 400

More info and screens

5

2. Health

2.1 Basic Checks

PRX has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
PRX has more shares outstanding than it did 1 year ago.
PRX has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, PRX has a worse debt to assets ratio.
PRX.AS Yearly Shares OutstandingPRX.AS Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B
PRX.AS Yearly Total Debt VS Total AssetsPRX.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B

2.2 Solvency

An Altman-Z score of 4.02 indicates that PRX is not in any danger for bankruptcy at the moment.
PRX's Altman-Z score of 4.02 is in line compared to the rest of the industry. PRX outperforms 50.00% of its industry peers.
PRX has a Debt/Equity ratio of 0.33. This is a healthy value indicating a solid balance between debt and equity.
PRX's Debt to Equity ratio of 0.33 is fine compared to the rest of the industry. PRX outperforms 66.67% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.33
Debt/FCF N/A
Altman-Z 4.02
ROIC/WACC0.01
WACC7.76%
PRX.AS Yearly LT Debt VS Equity VS FCFPRX.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 10B 20B 30B 40B 50B

2.3 Liquidity

PRX has a Current Ratio of 4.11. This indicates that PRX is financially healthy and has no problem in meeting its short term obligations.
PRX's Current ratio of 4.11 is amongst the best of the industry. PRX outperforms 100.00% of its industry peers.
A Quick Ratio of 4.05 indicates that PRX has no problem at all paying its short term obligations.
With an excellent Quick ratio value of 4.05, PRX belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 4.11
Quick Ratio 4.05
PRX.AS Yearly Current Assets VS Current LiabilitesPRX.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

More info and screens

6

3. Growth

3.1 Past

PRX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 22.02%, which is quite impressive.
Measured over the past years, PRX shows a decrease in Earnings Per Share. The EPS has been decreasing by -3.41% on average per year.
PRX shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 12.23%.
Measured over the past years, PRX shows a quite strong growth in Revenue. The Revenue has been growing by 15.54% on average per year.
EPS 1Y (TTM)22.02%
EPS 3Y6.31%
EPS 5Y-3.41%
EPS Q2Q%45.31%
Revenue 1Y (TTM)12.23%
Revenue growth 3Y2.24%
Revenue growth 5Y15.54%
Sales Q2Q%15.92%

3.2 Future

PRX is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 8.22% yearly.
Based on estimates for the next years, PRX will show a quite strong growth in Revenue. The Revenue will grow by 12.63% on average per year.
EPS Next Y66.43%
EPS Next 2Y41.18%
EPS Next 3Y32.14%
EPS Next 5Y8.22%
Revenue Next Year12.13%
Revenue Next 2Y13.14%
Revenue Next 3Y12.71%
Revenue Next 5Y12.63%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
PRX.AS Yearly Revenue VS EstimatesPRX.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2B 4B 6B 8B
PRX.AS Yearly EPS VS EstimatesPRX.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 1 2 3 4

More info and screens

5

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 14.82, the valuation of PRX can be described as correct.
The rest of the industry has a similar Price/Earnings ratio as PRX.
The average S&P500 Price/Earnings ratio is at 28.92. PRX is valued slightly cheaper when compared to this.
PRX is valuated reasonably with a Price/Forward Earnings ratio of 11.71.
Compared to the rest of the industry, the Price/Forward Earnings ratio of PRX indicates a somewhat cheap valuation: PRX is cheaper than 75.00% of the companies listed in the same industry.
PRX is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 21.65, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 14.82
Fwd PE 11.71
PRX.AS Price Earnings VS Forward Price EarningsPRX.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, PRX is valued expensively inside the industry as 83.33% of the companies are valued cheaper.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 469.31
PRX.AS Per share dataPRX.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PRX's earnings are expected to grow with 32.14% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.22
PEG (5Y)N/A
EPS Next 2Y41.18%
EPS Next 3Y32.14%

More info and screens

1

5. Dividend

5.1 Amount

With a yearly dividend of 0.27%, PRX is not a good candidate for dividend investing.
PRX's Dividend Yield is comparable with the industry average which is at 1.62.
With a Dividend Yield of 0.27, PRX pays less dividend than the S&P500 average, which is at 2.51.
Industry RankSector Rank
Dividend Yield 0.27%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

DPN/A
EPS Next 2Y41.18%
EPS Next 3Y32.14%
PRX.AS Yearly Income VS Free CF VS DividendPRX.AS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B 15B

More info and screens

PROSUS NV

AMS:PRX (4/25/2025, 5:05:15 PM)

40.745

+0.77 (+1.91%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustryBroadline Retail
Earnings (Last)12-02 2024-12-02
Earnings (Next)06-23 2025-06-23/amc
Inst Owners65.46%
Inst Owner ChangeN/A
Ins Owners0.74%
Ins Owner ChangeN/A
Market Cap96.93B
Analysts80.91
Price Target52.68 (29.29%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.27%
Yearly Dividend0.03
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)2.13%
PT rev (3m)6.61%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0.86%
EPS NY rev (3m)7.04%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.96%
Valuation
Industry RankSector Rank
PE 14.82
Fwd PE 11.71
P/S 18.77
P/FCF N/A
P/OCF N/A
P/B 2.3
P/tB 2.37
EV/EBITDA 469.31
EPS(TTM)2.75
EY6.75%
EPS(NY)3.48
Fwd EY8.54%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS2.17
BVpS17.7
TBVpS17.2
PEG (NY)0.22
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 11.3%
ROE 16.31%
ROCE 0.06%
ROIC 0.05%
ROICexc 0.06%
ROICexgc 0.07%
OM 0.66%
PM (TTM) 132.98%
GM 42.08%
FCFM N/A
ROA(3y)17.49%
ROA(5y)15.28%
ROE(3y)25.28%
ROE(5y)21.22%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-6.03%
PM growth 5Y-2.17%
GM growth 3Y7.78%
GM growth 5Y0.45%
F-ScoreN/A
Asset Turnover0.08
Health
Industry RankSector Rank
Debt/Equity 0.33
Debt/FCF N/A
Debt/EBITDA 75.53
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.11
Quick Ratio 4.05
Altman-Z 4.02
F-ScoreN/A
WACC7.76%
ROIC/WACC0.01
Cap/Depr(3y)91.16%
Cap/Depr(5y)76.21%
Cap/Sales(3y)3.47%
Cap/Sales(5y)3.16%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)22.02%
EPS 3Y6.31%
EPS 5Y-3.41%
EPS Q2Q%45.31%
EPS Next Y66.43%
EPS Next 2Y41.18%
EPS Next 3Y32.14%
EPS Next 5Y8.22%
Revenue 1Y (TTM)12.23%
Revenue growth 3Y2.24%
Revenue growth 5Y15.54%
Sales Q2Q%15.92%
Revenue Next Year12.13%
Revenue Next 2Y13.14%
Revenue Next 3Y12.71%
Revenue Next 5Y12.63%
EBIT growth 1Y110.51%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year183.8%
EBIT Next 3Y58.98%
EBIT Next 5YN/A
FCF growth 1Y231.66%
FCF growth 3Y154.72%
FCF growth 5YN/A
OCF growth 1Y424.77%
OCF growth 3Y63.5%
OCF growth 5YN/A